Neuroinflammation as the proximate cause of signature pathogenic pattern progression in amyotrophic lateral sclerosis, aids, and multiple sclerosis

Pathology Research International

Volumn 2012, Issue , 2012, Pages

  Agius, Lawrence M ^a  

^a UNIVERSITY OF MALTA MEDICAL SCHOOL   (Malta)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84871829395     PISSN: None     EISSN: 2042003X     Source Type: Journal    
DOI: 10.1155/2012/169270     Document Type: Review

References (32)

1. Pizza V., Agresta A., ĎAcunto C. W., Festa M., Capasso A., Neuroinflamm-aging and neurodegenerative diseases: an overview. CNS and Neurological Disorders 2011 10 5 621 634 2-s2.0-79959955207
2. Sako W., Ito H., Yoshida M., Nuclear factor kB expression in patients with sporadic amyotrophic lateral sclerosis and hereditary amyotrophic lateral sclerosis with optineurin mutations. Clinical Neuropathology 2012 31 6 418 423
3. Jablonski M. R., Jacob D. A., Campos C., Miller D. S., Maragakis N. J., Pasinelli P., Trotti D., Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS. Neurobiology of Disease 2012 47 2 194 200 10.1016/j.nbd.2012.03.040
4. Ticozzi N., Tiloca C., Mencacc N. E., Oligoclonal bands in the cerebrospinal fluid of amyotrophic lateral sclerosis patients with disease-associated mutations. Journal of Neurology. In press
5. Liao B., Zhao W., Beers D. R., Henkel J. S., Appel S. H., Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Experimental Neurology 2012 237 1 147 152 10.1016/j.expneurol.2012.06.011
6. Appel S. H., Zhao W., Beers D. R., Henkel J. S., The microglial- motoneuron dialogue in ALS. Acta Myologica 2011 30 1 4 8 2-s2.0-79958022133
7. Lewis C.-A., Manning J., Rossi F., Krieger C., The neuroinflammatory response in ALS: the roles of microglia and T cells. Neurology Research International 2012 2012 803701 10.1155/2012/803701
8. Contestabile A., Amyotrophic lateral sclerosis: from research to therapeutic attempts and therapeutic perspectives. Current Medicinal Chemistry 2011 18 36 5655 5665
9. Williams D. W., Eugenin E. A., Calderon T. M., Berman J. W., Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis. Journal of Leukocyte Biology 2012 91 3 401 415 10.1189/jlb.0811394
10. Philips T., Robberecht W., Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. The Lancet Neurology 2011 10 3 253 263 2-s2.0-79951704433 10.1016/S1474-4422(11)70015-1
11. Patel J., Balabanov R., Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis. International Journal of Molecular Sciences 2012 13 8 10647 10659
12. Berger J. V., Dumont A. O., Focant M. C., Opposite regulation of metabotrophic glutamate receptor 3 and metabotropic glutamate receptor 5 by inflammatory stimuli in cultured microglia and astrocytes. Neuroscience 2012 205 29 38 10.1016/j.neuroscience.2011.12.044
13. Aebischer J., Moumen A., Sazdovitch V., Seilhean D., Meininger V., Raoul C., Elevated levels of IFNy and LIGHT in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. European Journal of Neurology 2012 19 5 752 759
14. Williams K., Burdo T. H., Monocyte mobilization, activation markers, and unique macrophage populations in the brain: observations from SIV Infected monkeys are informative with regard to pathogenic mechanisms of HIV infection in humans. Journal of Neuroimmune Pharmacology 2012 7 2 363 371 10.1007/s11481-011-9330-3
15. Li G., Esiri M. M., Ansorge O., DeLuca G. C., Concurrent multiple sclerosis and amyotrophic lateral sclerosis: where inflammation and neurodegeneration meet? Journal of Neuroinflammation 2012 9 20 10.1186/1742-2094-9-20
16. Krumbholz M., Derfuss T., Hohlfeld R., Meinl E., B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nature Reviews Neurology 2012 8 11 613 623 10.1038/nrneurol.2012.203
17. Karmon Y., Ramanathan M., Minagar A., Zivadinov R., Weinstock-Guttman B., Arterial, venous and other vascular risk factors in multiple sclerosis. Neurological Research 2012 34 8 754 760 10.1179/1743132812Y.0000000077
18. Valente T., Mancera P., Tusell J. M., Serratosa J., Saura J., C/EBP β expression in activated microglia in amyotrophic lateral sclerosis. Neurobiology of Aging 2012 33 9 2186 2199 10.1016/j.neurobiolaging.2011.09.019
19. Lassmann H., van Horssen J., Mahad D., Progressive multiple sclerosis: pathology and pathogenesis. Nature Reviews Neurology 2012 8 11 647 656 10.1038/nrneurol.2012.168
20. Khansari P. S., Sperlagh B., Inflammation in neurological and psychiatric diseases. Inflammopharmacology 2012 20 3 103 107 10.1007/s10787-012-0124-x
21. Buassat D., When does multiple sclerosis start? Three case reports and a review of the literature. Revue Neurologique 2012 168 11 846 851 10.1016/j.neurol.2012.07.009
22. Finkelstein A., Kunis G., Seksenyan A., Ronen A., Berkutzki T., Azoulay D., Koronyo-Hamaoui M., Schwartz M., Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS. PLoS One 2011 6 8 2-s2.0-79960987739 10.1371/journal.pone.0022374 e22374
23. Wada A., Roles of voltage-dependent sodium channels in neuronal development, pain, and neurodegeneration. Journal of Pharmacological Sciences 2006 102 3 253 268 2-s2.0-33751229668 10.1254/jphs.CRJ06012X (Pubitemid 44790687)
24. Swarup V., Phaneuf D., Barcil C., Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Brain 2011 134, part 9 2610 2626
25. Casula M., Iyer A. M., Spliet W. G. M., Anink J. J., Steentjes K., Sta M., Troost D., Aronica E., Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue. Neuroscience 2011 179 233 243 2-s2.0-79952619563 10.1016/j.neuroscience.2011.02.001
26. Bingham R., Ahmed N., Rangi P., Johnson M., Tyrer M., Green J., HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape. International Journal of STD and AIDS 2011 22 10 608 609 10.1258/ijsa.2011.010507
27. Doyle K. M., Kennedy D., Gorman A. M., Gupta S., Healy S. J. M., Samali A., Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders. Journal of Cellular and Molecular Medicine 2011 15 10 2025 2039 10.1111/j.1582-4934.2011.01374.x
28. Kaushik D. K., Gupta M., Basu A., Microglial response to viral challenges: every silver lining comes with a cloud. Frontiers in Bioscience 2011 16 6 2187 2205 2-s2.0-79959769249 10.2741/3847
29. Joyce P. I., Fratta P., Fisher E. M. C., Acevedo-Arozena A., SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments. Mammalian Genome 2011 22 7-8 420 448 2-s2.0-79959464079 10.1007/s00335-011-9339-1
30. Volonté C., Apolloni S., Carrì M. T., D'Ambrosi N., ALS: focus on purinergic signalling. Pharmacology and Therapeutics 2011 132 1 111 122 2-s2.0-79960618487 10.1016/j.pharmthera.2011.06.002
31. Grammas P., Martinez J., Miller B., Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases. Expert Reviews in Molecular Medicine 2011 13 e19 10.1017/S1462399411001918
32. Evans M. C., Couch Y., Sibson N., Inflammation and neurovascular changes in amyotrophic lateral sclerosis. Molecular and Cellular Neuroscience. In press